COVID-19 and haematological malignancy: navigating a narrow strait
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Patients with haematological malignancies face unique infectious risks. Not only do their cancers typically directly affect the immune system, but therapies can cause severe myelosuppression and lymphodepletion, especially in curative settings. Vigilance to avoid life-threatening infection is a part of life for these patients and is crucial in medical decision making. With this context, the COVID-19 pandemic has understandably shaken this community, and more data to guide management are needed. (...)
The Lancet Haematology , commentaire en libre accès, 2019